Stephen CabralStephen Cabral Facebook ad: “In a large human study, nattokinase was shown…”
Ran for 236 days, from February 10 to October 4, 2026, the last day Crush saw it.
Run by Stephen Cabral on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 2002763603638090
- Platforms
- Relaunches
- 0
Ad text
In a large human study, nattokinase was shown to reduce arterial plaque up to 3× more than statins. Even more impressive: It helped lower triglycerides It helped increase healthy HDL cholesterol And it did this without many of the common side effects associated with statins Nattokinase works by breaking down excess fibrin and supporting healthy blood flow, addressing the underlying process of plaque buildup rather than just suppressing cholesterol numbers. This is why it’s been used in functional medicine for years as part of a comprehensive heart health approach. If you’re interested in the Nattokinase product we use in our practice, comment PLAQUE below, and I’ll send it over with a 15% discount.
